Massachusetts General Hospital
Hagai Marmor-Kollet is a highly experienced scientist currently serving as a Senior Scientist at both Massachusetts General Hospital and Harvard Medical School since February 2024, while also working as a Consultant and Research Team Leader at 1E Therapeutics since July 2021. At 1E Therapeutics, Hagai has spearheaded the Structure-Activity Relationship campaign and conducted high-throughput screening of lead molecules against KRAS, contributing to significant funding achievements. As a co-founder of the Weizmann Biotech Club, Hagai established an innovative networking forum for biotech professionals and graduate students in Israel. Previously, Hagai held various research and teaching roles, including Associate Researcher at Rosetta Genomics and Teaching Assistant at the Weizmann Institute of Science. Hagai's academic qualifications include a PhD and a Master's Degree in Molecular Biology from the Weizmann Institute of Science, alongside a Bachelor's degree in Chemistry and Biology from The Hebrew University of Jerusalem. Prior military service includes a captaincy in the Golani Brigade of the Israel Defense Forces.
This person is not in any teams